finance

Chair of digital chemistry pioneer quits



James Ede-Golightly is to step down as chair of Glasgow-based ‘digital chemistry’ pioneer DeepMatter.

The made the announcement as the AIM-listed firm said impact of the pandemic has coincided with increased interest in its DigitalGlassware software, which enables better remote working by scientists.

In its annual results, DeepMatter Group reported turnover of £1.2 million, comprising its first revenue from DigitalGlassware and income from InfoChem GmbH, the German firm it acquired last year.

Losses after tax from continuing operations widened to £3.02 million from £1.81 million the previous year.

During 2019, it received its first purchase order for DigitalGlassware from o2h discovery, and announced a collaboration with pharma giant AstraZeneca. The software platform enables chemists anywhere in the world to share research data remotely through cloud technology, so reducing the need for duplicated experiments and speeding up drug development.

Ede-Golightly, who is also chairman of Quoram and a director of Silence Therapeutics, said: “As part of the continuing evolution of the Board I will be retiring as a Director of the Company at the 2020 AGM, having served as a Director since 2014. The Board is in discussion with candidates and expects to announce the appointment of a Non-Executive Chairperson later in the year.

CEO Mark Warne said: “I am pleased with the progress that the Group made during 2019, delivering the first revenues for DigitalGlassware™ and executing on all the strategic objectives for the year. The integration of InfoChem is now successfully complete, with the acquisition contributing to the Group’s overall revenues, while adding technological capabilities and customers.

“I cannot speak highly enough of our employees who, following the year end, have risen to the challenge and uncertainty created by the COVID-19 pandemic, including serving our customers professionally via remote working and enabling the Company to act to safeguard the business, ensuring tight control of costs and hence preserving our resources.

“As a business we continue to capitalise on the established sales pipeline, but as our customer base adapts its working practices within laboratories as a result of social distancing practices, we see increased interest in the need to share scientific data both remotely and within the lab, accelerating the digitisation of the laboratory and underlining the value proposition of the DigitalGlassware platform.”



READ SOURCE

Leave a Reply